Eric Zhang
Algemeen Directeur bij AKSO Biopharmaceutical, Inc.
Vermogen: 174 010 $ op 31-12-2023
Actieve functies van Eric Zhang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AKSO Biopharmaceutical, Inc. | Algemeen Directeur | - | - |
| Oprichter | - | - |
Loopbaan van Eric Zhang
Eerdere bekende functies van Eric Zhang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ARAVIVE, INC. | Directeur/Bestuurslid | 12-10-2018 | 02-10-2023 |
| Independent Dir/Board Member | 12-10-2018 | 02-10-2023 | |
Aravive Biologics, Inc.
 Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Directeur/Bestuurslid | 01-06-2016 | 01-10-2018 |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Directeur/Bestuurslid | 12-10-2018 | - |
Opleiding van Eric Zhang
| Queen's University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Canada | 2 |
Operationeel
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ARAVIVE, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Health Technology |
Aravive Biologics, Inc.
Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Health Technology |
| AKSO Biopharmaceutical, Inc. |
- Beurs
- Insiders
- Eric Zhang
- Ervaring
